Elanco Animal Health Inc
F:5EA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Elanco Animal Health Inc
F:5EA
|
US |
|
S
|
Siam Wellness Group PCL
SET:SPA
|
TH |
|
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
CA |
|
Lifeline SPAC I Oyj
F:0CD
|
FI |
|
Dal'nevostochnoye Morskoye Parokhodstvo PAO
MOEX:FESH
|
RU |
|
Kinarus Therapeutics Holding AG
SIX:CURN
|
CH |
|
Vitura Health Ltd
ASX:VIT
|
AU |
|
M
|
Marks and Spencer Group PLC
DUS:MA6
|
UK |
|
T
|
Thai Stanley Electric PCL
SET:STANLY
|
TH |
|
Sulzer AG
SIX:SUN
|
CH |
|
F
|
Fairvest Ltd
JSE:FTA
|
ZA |
Wall St Price Targets
5EA Price Targets Summary
Elanco Animal Health Inc
According to Wall Street analysts, the average 1-year price target for 5EA is 24.44 EUR with a low forecast of 19.633 EUR and a high forecast of 27.214 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5EA's stock price target?
Price Target
24.44
EUR
According to Wall Street analysts, the average 1-year price target for 5EA is 24.44 EUR with a low forecast of 19.633 EUR and a high forecast of 27.214 EUR.
What is the Revenue forecast for Elanco Animal Health Inc?
Projected CAGR
4%
Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Elanco Animal Health Inc?
Projected CAGR
23%
Over the last 11 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 8 years is 23%.
